US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Processa Pharmaceuticals, Inc.

News headline image
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
News headline image
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
News headline image
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
News headline image
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
News headline image
PCS12852 Improves Gastric Emptying in Gastroparesis Patients
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
News headline image
Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
News headline image
Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B Trial
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA